Wellbutrin XL Generic Could Launch Later This Year
This article was originally published in The Pink Sheet Daily
Executive Summary
A generic version of GlaxoSmithKline's antidepressant Wellbutrin XL (bupropion) could launch later this year after an Aug. 1 decision in a California district court
You may also be interested in...
Watson Gets $35 Million From GSK In Wellbutrin XL Patent Dispute
Firm will receive one-time payment from GlaxoSmithKline to settle claims the Wellbutrin marketer infringed its bupropion patent.
Watson Gets $35 Million From GSK In Wellbutrin XL Patent Dispute
Firm will receive one-time payment from GlaxoSmithKline to settle claims the Wellbutrin marketer infringed its bupropion patent.
Teva's Generic Wellbutrin XL For Major Depressive Disorder Launches
GSK has more than two years to market Wellbutrin XL in seasonal affective disorder before generics for that indication can launch.